OTHERS DISTRIBUTION OF DIAGNOSTIC KIT FOR ANTIBODY IGM/IGG OF NOVEL CORONAVIRUS COVID-19 MANUFACTURED BY SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO. LTD

HO WAH GENTING BERHAD

Type Announcement
Subject OTHERS
Description
DISTRIBUTION OF DIAGNOSTIC KIT FOR ANTIBODY IGM/IGG OF NOVEL CORONAVIRUS COVID-19 MANUFACTURED BY SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO. LTD

The Board of Directors wishes to announce that HWG Consortium Sdn Bhd (“HWGC”), a wholly owned subsidiary of HWGB, had on 15 May 2020 being appointed as the authorised distributor of Shanghai Liangrun Biomedicine Technology Co., Ltd (“Shanghai Liangrun”) for the distribution of its antibody IgM/IgG Of Novel Coronavirus Covid-19 diagnostic kit (“Diagnostic Kit”) in Malaysia for a validity period from 15 May 2020 to 31 December 2020.  HWGC had also submitted an application to the Ministry of Health, Malaysia for the certification of the Diagnostic Kit and is currently pending approval.

 

Further, HWGC had also on 15 May 2020 appointed PM Care Sdn Bhd (“PM Care”) as the non-exclusive sub-distributor of the diagnostic kit for the distribution of the Diagnostic Kit.

 

INFORMATION ON SHANGHAI LIANGRUN

 

Shanghai Liangrun with its principal place of business at Level 4, Building 1, No.271 Gang'ao Road, Pilot Free Trade Zone, Shanghai, China is a company principally engaged in the biomedicine technology.

 

INFORMATION ON PM CARE

 

PM Care with its principal place of business at No.1, Jalan USJ 21/10, UEP Subang Jaya, 47630 Selangor, is the pioneer and leading third party administrator (TPA) in Malaysia in collaboration with a network of more than 3,500 medical providers nationwide.

 

 

This announcement is dated 15 May 2020.






Announcement Info

Company Name HO WAH GENTING BERHAD
Stock Name HWGB
Date Announced 15 May 2020
Category General Announcement for PLC
Reference Number GA1-15052020-00099